Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Blanck

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Molecular and Clinical Oncology|December 30, 2017
MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor developmentJohn M Yavorski, George Blanck
Cell Cycle (Georgetown, Tex.)|June 30, 2016
TCGA: Increased oncoprotein coding region mutations correlate with a greater expression of apoptosis-effector genes and a positive outcome for stomach adenocarcinomaJohn M Yavorski, George Blanck
Gene|December 3, 2013
Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancerJames A Mauro, George Blanck
Oncology Letters|October 6, 2016
Overlap of the cancer genome atlas and the immune epitope databaseShaimaa Sait, Timothy Fawcett, George Blanck
Anticancer Research|November 30, 2005
CIITA transformation rescues the apoptotic function of MHC class II in melanoma cellsElizabeth Le, Hongquan Zhang, George Blanck
Molecular Immunology|December 20, 2005
Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell lineAaron R Osborne, Hongquan Zhang, George Blanck
Molecular Immunology|October 28, 2008
Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuitLijun Xu, Melissa I Niesen, George Blanck
Cancer Letters|December 3, 2014
Big genes are big mutagen targets: a connection to cancerous, spherical cells?Michele L Parry, Michael Ramsamooj, George Blanck
Cell Cycle (Georgetown, Tex.)|November 6, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastomaSaif Zaman, Boris I Chobrutskiy, George Blanck
Immunologic Research|March 30, 2018
T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival ratesBlake M Callahan, Wei Lue Tong, George Blanck
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Molecular and Clinical Oncology|December 30, 2017
MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor developmentJohn M Yavorski, George Blanck
Cell Cycle (Georgetown, Tex.)|June 30, 2016
TCGA: Increased oncoprotein coding region mutations correlate with a greater expression of apoptosis-effector genes and a positive outcome for stomach adenocarcinomaJohn M Yavorski, George Blanck
Gene|December 3, 2013
Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancerJames A Mauro, George Blanck
Oncology Letters|October 6, 2016
Overlap of the cancer genome atlas and the immune epitope databaseShaimaa Sait, Timothy Fawcett, George Blanck
Anticancer Research|November 30, 2005
CIITA transformation rescues the apoptotic function of MHC class II in melanoma cellsElizabeth Le, Hongquan Zhang, George Blanck
Molecular Immunology|December 20, 2005
Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell lineAaron R Osborne, Hongquan Zhang, George Blanck
Molecular Immunology|October 28, 2008
Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuitLijun Xu, Melissa I Niesen, George Blanck
Cancer Letters|December 3, 2014
Big genes are big mutagen targets: a connection to cancerous, spherical cells?Michele L Parry, Michael Ramsamooj, George Blanck
Cell Cycle (Georgetown, Tex.)|November 6, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastomaSaif Zaman, Boris I Chobrutskiy, George Blanck
Immunologic Research|March 30, 2018
T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival ratesBlake M Callahan, Wei Lue Tong, George Blanck
Pageof 15